Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia

被引:3
作者
Gaut, Daria [1 ,8 ]
Oliai, Caspian [1 ]
Boiarsky, Jonathan [1 ]
Zhang, Shiliang [1 ]
Salhotra, Amandeep [2 ]
Azenkot, Tali [3 ]
Kennedy, Vanessa E. [4 ]
Khanna, Vishesh [5 ]
Olmedo Gutierrez, Karla [6 ]
Shukla, Navika [7 ]
Moskoff, Benjamin [3 ]
Park, Gabriel [2 ]
Afkhami, Michelle [2 ]
Patel, Anand [7 ]
Jeyakumar, Deepa [6 ]
Mannis, Gabriel [5 ]
Logan, Aaron C. [4 ]
Jonas, Brian A. [3 ]
Schiller, Gary [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA
[2] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplant, Duarte, CA USA
[3] Univ Calif Davis, Dept Med, Div Hematol Oncol, Sch Med, Sacramento, CA USA
[4] Univ Calif San Francisco, Sch Med, Dept Med, Div Hematol Oncol, San Francisco, CA USA
[5] Stanford Canc Inst, Dept Med, Div Hematol, Stanford, CA USA
[6] Univ Calif Irvine, Sch Med, Dept Med, Div Hematol Oncol, Orange, CA USA
[7] Univ Chicago, Dept Med, Div Hematol Oncol, Chicago, IL USA
[8] Univ Calif Los Angeles, David Geffen Sch Med, 200 UCLA Med Plaza,Suite 120, Los Angeles, CA 90095 USA
关键词
Acute myeloid leukemia; measurable residual disease; consolidation chemotherapy; allogeneic hematopoietic stem cell transplantation; HEMATOPOIETIC-CELL TRANSPLANTATION; MULTIPARAMETER FLOW-CYTOMETRY; COMPLETE REMISSION; OLDER PATIENTS; IMPACT; MRD; AML; HOVON/SAKK; INDUCTION; SURVIVAL;
D O I
10.1080/10428194.2023.2264426
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The rate of MRD clearance in AML with standard consolidation chemotherapy is not well defined. A multi-institution retrospective analysis was performed on 107 consecutively treated AML patients in morphologic complete remission with detectable MRD post-induction therapy who received standard chemotherapy consolidation. In response to standard intermediate/high-dose cytarabine consolidation therapy, 26 of 60 patients (43.3%) with MRD threshold of detection of at least 0.1% converted to MRD-negative status (undetectable with assay used), and 6 of 47 patients (12.8%) with MRD threshold of detection > 0.1% converted to MRD-negative status. Multivariable logistic regression for patients with MRD threshold of detection of at least 0.1% showed that, when controlling for age, ELN risk category, dose of cytarabine, and use of a combination agent, treatment with 1 cycle of consolidation cytarabine versus >= 2 cycles decreased the odds of conversion of AML to MRD-negative (OR = 0.24, 95% CI 0.07-0.85, p = 0.03).
引用
收藏
页码:69 / 77
页数:9
相关论文
共 28 条
[1]   Additional Cytotoxic Chemotherapy Is Unlikely to Eliminate Measurable Residual Acute Myeloid Leukemia (AML) [J].
Appelbaum, Jacob ;
Loeb, Anisha ;
Gardner, Kelda ;
Shaw, Carole M. ;
Hendrie, Paul C. ;
Godwin, Colin D. ;
Percival, Mary-Elizabeth M. ;
Halpern, Anna B. ;
Scott, Bart L. ;
Oehler, Vivian G. ;
Walter, Roland B. ;
Becker, Pamela S. ;
Jensen, Michael C. ;
Estey, Elihu H. .
BLOOD, 2019, 134
[2]   Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission? [J].
Araki, Daisuke ;
Wood, Brent L. ;
Othus, Megan ;
Radich, Jerald P. ;
Halpern, Anna B. ;
Zhou, Yi ;
Mielcarek, Marco ;
Estey, Elihu H. ;
Appelbaum, Frederick R. ;
Walter, Roland B. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04) :329-+
[3]   Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association Group [J].
Balsat, Marie ;
Renneville, Aline ;
Thomas, Xavier ;
de Botton, Stephane ;
Caillot, Denis ;
Marceau, Alice ;
Lemasle, Emilie ;
Marolleau, Jean-Pierre ;
Nibourel, Olivier ;
Berthon, Celine ;
Raffoux, Emmanuel ;
Pigneux, Arnaud ;
Rodriguez, Celine ;
Vey, Norbert ;
Cayuela, Jean-Michel ;
Hayette, Sandrine ;
Braun, Thorsten ;
Coude, Marie Magdeleine ;
Terre, Christine ;
Celli-Lebras, Karine ;
Dombret, Herve ;
Preudhomme, Claude ;
Boissel, Nicolas .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (02) :185-+
[4]   Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease [J].
Bataller, Alex ;
Onate, Guadalupe ;
Diaz-Beya, Marina ;
Guijarro, Francesca ;
Garrido, Ana ;
Vives, Susana ;
Tormo, Mar ;
Arnan, Montserrat ;
Salamero, Olga ;
Sampol, Antonia ;
Coll, Rosa ;
Vall-Llovera, Ferran ;
Oliver-Caldes, Aina ;
Lopez-Guerra, Monica ;
Pratcorona, Marta ;
Zamora, Lurdes ;
Villamon, Eva ;
Rou, Gael ;
Blanco, Adoracion ;
Nomdedeu, Josep F. ;
Colomer, Dolors ;
Brunet, Salut ;
Sierra, Jorge ;
Esteve, Jordi .
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (01) :52-61
[5]   The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia [J].
Buccisano, F. ;
Maurillo, L. ;
Gattei, V. ;
Del Poeta, G. ;
Del Principe, M. I. ;
Cox, M. C. ;
Panetta, P. ;
Consalvo, M. Irno ;
Mazzone, C. ;
Neri, B. ;
Ottaviani, L. ;
Fraboni, D. ;
Tamburini, A. ;
Lo-Coco, F. ;
Amadori, S. ;
Venditti, A. .
LEUKEMIA, 2006, 20 (10) :1783-1789
[6]   Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis [J].
Buckley, Sarah A. ;
Wood, Brent L. ;
Othus, Megan ;
Hourigan, Christopher S. ;
Ustun, Celalettin ;
Linden, Michael A. ;
DeFor, Todd E. ;
Malagola, Michele ;
Anthias, Chloe ;
Valkova, Veronika ;
Kanakry, Christopher G. ;
Gruhn, Bernd ;
Buccisano, Francesco ;
Devine, Beth ;
Walter, Roland B. .
HAEMATOLOGICA, 2017, 102 (05) :865-873
[7]   Persistence of Cytogenetic Abnormalities at Complete Remission After Induction in Patients With Acute Myeloid Leukemia: Prognostic Significance and the Potential Role of Allogeneic Stem-Cell Transplantation [J].
Chen, Yiming ;
Cortes, Jorge ;
Estrov, Zeev ;
Faderl, Stefan ;
Qiao, Wei ;
Abruzzo, Lynne ;
Garcia-Manero, Guillermo ;
Pierce, Sherry ;
Huang, Xuelin ;
Kebriaei, Partow ;
Kadia, Tapan ;
De Lima, Marcos ;
Kantarjian, Hagop ;
Ravandi, Farhad .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) :2507-2513
[8]   DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant [J].
Dillon, Laura W. ;
Gui, Gege ;
Page, Kristin M. ;
Ravindra, Niveditha ;
Wong, Zoe C. ;
Andrew, Georgia ;
Mukherjee, Devdeep ;
Zeger, Scott L. ;
El Chaer, Firas ;
Spellman, Stephen ;
Howard, Alan ;
Chen, Karen ;
Auletta, Jeffery ;
Devine, Steven M. ;
Jimenez, Antonio Martin Jimenez ;
De Lima, Marcos J. G. ;
Litzow, Mark R. ;
Kebriaei, Partow ;
Saber, Wael ;
Weisdorf, Daniel J. ;
Hourigan, Christopher S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (09) :745-755
[9]   Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN [J].
Doehner, Hartmut ;
Wei, Andrew H. ;
Appelbaum, Frederick R. ;
Craddock, Charles ;
DiNardo, Courtney D. ;
Dombret, Herve ;
Ebert, Benjamin L. ;
Fenaux, Pierre ;
Godley, Lucy A. ;
Hasserjian, Robert P. ;
Larson, Richard A. ;
Levine, Ross L. ;
Miyazaki, Yasushi ;
Niederwieser, Dietger ;
Ossenkoppele, Gert ;
Roellig, Christoph ;
Sierra, Jorge ;
Stein, Eytan M. ;
Tallman, Martin S. ;
Tien, Hwei-Fang ;
Wang, Jianxiang ;
Wierzbowska, Agnieszka ;
Lowenberg, Bob .
BLOOD, 2022, 140 (12) :1345-1377
[10]   Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].
Doehner, Hartmut ;
Estey, Elihu ;
Grimwade, David ;
Amadori, Sergio ;
Appelbaum, Frederick R. ;
Buechner, Thomas ;
Dombret, Herve ;
Ebert, Benjamin L. ;
Fenaux, Pierre ;
Larson, Richard A. ;
Levine, Ross L. ;
Lo-Coco, Francesco ;
Naoe, Tomoki ;
Niederwieser, Dietger ;
Ossenkoppele, Gert J. ;
Sanz, Miguel ;
Sierra, Jorge ;
Tallman, Martin S. ;
Tien, Hwei-Fang ;
Wei, Andrew H. ;
Lowenberg, Bob ;
Bloomfield, Clara D. .
BLOOD, 2017, 129 (04) :424-447